{"title":"熊，甜菜，利福昔明。","authors":"Peter L Wang, Jennifer A Flemming","doi":"10.3138/canlivj-2021-0026","DOIUrl":null,"url":null,"abstract":"over-all makeup of the gut flora. In the last 20 years, rifaximin has developed a well-established role in the secondary prevention of HE (3,4), yet surpris-ingly, its efficacy has not been supported for its use in primary prevention (5). One of the major risk factors for the development of HE is undergoing a transjugular intrahepatic portosystemic shunt (TIPS) procedure, typically performed for compli-cations of portal hypertension, including refractory ascites and variceal bleeding. TIPS predisposes","PeriodicalId":9527,"journal":{"name":"Canadian liver journal","volume":" ","pages":"438-442"},"PeriodicalIF":0.0000,"publicationDate":"2021-11-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9235125/pdf/canlivj-2021-0026.pdf","citationCount":"0","resultStr":"{\"title\":\"Bears, beets, rifaximin.\",\"authors\":\"Peter L Wang, Jennifer A Flemming\",\"doi\":\"10.3138/canlivj-2021-0026\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"over-all makeup of the gut flora. In the last 20 years, rifaximin has developed a well-established role in the secondary prevention of HE (3,4), yet surpris-ingly, its efficacy has not been supported for its use in primary prevention (5). One of the major risk factors for the development of HE is undergoing a transjugular intrahepatic portosystemic shunt (TIPS) procedure, typically performed for compli-cations of portal hypertension, including refractory ascites and variceal bleeding. TIPS predisposes\",\"PeriodicalId\":9527,\"journal\":{\"name\":\"Canadian liver journal\",\"volume\":\" \",\"pages\":\"438-442\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2021-11-11\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9235125/pdf/canlivj-2021-0026.pdf\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Canadian liver journal\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.3138/canlivj-2021-0026\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2021/1/1 0:00:00\",\"PubModel\":\"eCollection\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Canadian liver journal","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.3138/canlivj-2021-0026","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2021/1/1 0:00:00","PubModel":"eCollection","JCR":"","JCRName":"","Score":null,"Total":0}
over-all makeup of the gut flora. In the last 20 years, rifaximin has developed a well-established role in the secondary prevention of HE (3,4), yet surpris-ingly, its efficacy has not been supported for its use in primary prevention (5). One of the major risk factors for the development of HE is undergoing a transjugular intrahepatic portosystemic shunt (TIPS) procedure, typically performed for compli-cations of portal hypertension, including refractory ascites and variceal bleeding. TIPS predisposes
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
